Two stocks that Osho Krishan of Anand Rathi is bullish on

Rossari Biotech has been in a secular uptrend and is placed well above all the major exponential moving averages on the daily charts

Markets, stocks, buy, sell, trading, shares, stock market
Osho Krishan Mumbai
1 min read Last Updated : Sep 03 2021 | 7:48 AM IST
BUY ROSSARI BIOTECH LTD | TARGET: Rs 1,560 | STOP LOSS: Rs 1,360

ROSSARI BIOTECH has been in a secular uptrend and is placed well above all the major exponential moving averages on the daily charts, suggesting inherent strength in the stock. Alongside, it formed a strong bullish candle in the last trading session on the back of an increase in average traded volumes, affirming the bullish stance. On the oscillator front, 14 period RSI has been trading in higher region post positive crossover assuring the strength in the up move and the stock seems to test the uncharted territory.

BUY STRIDES PHARMA SCIENCE LTD | TARGET: Rs 660 | STOP LOSS: Rs 580

STRIDES PHARMA SCIENCE has seen a massive correction in recent times and is currently is hovering near the 50% Fibonacci retracement of the rally. However, last week, the counter had formed a ‘hammer’ candlestick pattern, indicating the initial sign of trend reversal. Further, the 14 period RSI reversed its trend from the oversold region and has gradually started to surge post positive crossover, affirming strengthening demand zone at lower levels.

===================================================
Osho Krishan is senior manager – Equity Research at Anand Rathi Shares & Stock Brokers. Views are personal.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Stock ideasMarket technicalsMarketsStock PicksStock RecommendationsStocks to buy todayStock callsTrading callsAnand Rathi

Next Story